None listed
Conditions
Interventions
Intervention1: Ketorolac: Available as a dispersible tablet administered per orally. It is an acetic acid derivative type of Non Steroidal Anti Inflammatory Drug (NSAID)
Dosage: 10 mg
Frequency: 8 ho
Sponsors
Dr Esha Verma
Eligibility
Inclusion criteria
Inclusion criteria: Presence of impacted/partially erupted mandibular third molar requiring surgical removal
Exclusion criteria
Exclusion criteria: - Known hypersensitivity to NSAIDs - History of asthma, cardiac abnormalities, liver and kidney diseases - Patient under anti-platelet medications - Active peptic ulcer disease or bleeding disorder - Pregnancy or lactation - History of chronic analgesic use
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessing pain score with the Numerical Rating ScaleTimepoint: 24, 48 and 72 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation of pain with impaction difficultyTimepoint: 24 hour, 48 hours & 72 hours;Incidence of complications (swelling, trismus, alveolar osteitis, infection)Timepoint: At 1 week | — |
Countries
India
Contacts
Public ContactEsha Verma
A B Shetty Memorial Institute of Dental Sciences
Outcome results
None listed